Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma

The treatment of metastatic melanoma has evolved from an era where interferon and chemotherapy were the mainstay of treatments to an era where immunotherapy has become the frontline. Ipilimumab (IgG1 CTLA-4 inhibitor), nivolumab (IgG4 PD-1 inhibitor), pembrolizumab (IgG4 PD-1 inhibitor) and nivoluma...

Descripción completa

Detalles Bibliográficos
Autores principales: Babiker, Hani M, Riaz, Irbaz Bin, Husnain, Muhammad, Borad, Mitesh J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308590/
https://www.ncbi.nlm.nih.gov/pubmed/28224120
http://dx.doi.org/10.2147/OV.S100072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308590/
https://www.ncbi.nlm.nih.gov/pubmed/28224120
http://dx.doi.org/10.2147/OV.S100072

Ejemplares similares